Avg closing price
Price range

13 Joel Greenblatt Veracyte Trades

Joel Greenblatt acquired 11.5 Thousand Veracyte shares worth $250 Thousand. That's 0.00% of their equity portfolio (1165th largest holding). The first Veracyte trade was made in Q2 2019. Since then Joel Greenblatt bought shares five more times and sold shares on seven occasions. The investor's estimated purchase price is $265 Thousand, resulting in a loss of 5.4%.

Avg closing price
Price range
Sold 74.6% shares (-33.8 Thousand shares) Q4 2023
Avg closing price $24.14
Price range $19.72 - $28.68
Increased shares by 85.7% (+20.9 Thousand shares) Q3 2023
Avg closing price $25.72
Price range $22.33 - $29.92
Increased shares by 101.4% (+12.3 Thousand shares) Q2 2023
Avg closing price $24.24
Price range $20.96 - $26.99
Sold 82.7% shares (-58.1 Thousand shares) Q1 2023
Avg closing price $24.17
Price range $20.58 - $27.89
Increased shares by 137.9% (+40.7 Thousand shares) Q4 2022
Avg closing price $23.24
Price range $15.31 - $29.94
Sold 3.2% shares (-960 shares) Q3 2022
Avg closing price $22.50
Price range $16.58 - $27.90
New holding (+30.5 Thousand shares) Q2 2022
Avg closing price $20.20
Price range $15.45 - $29.52
Sold -30.3 Thousand shares Q4 2021
Avg closing price $44.18
Price range $36.09 - $53.79
New holding (+30.3 Thousand shares) Q3 2021
Avg closing price $43.64
Price range $35.62 - $52.97
Sold -9.47 Thousand shares Q1 2020
Avg closing price $25.17
Price range $16.13 - $30.17
Sold 65.7% shares (-18.1 Thousand shares) Q4 2019
Avg closing price $25.89
Price range $20.78 - $29.99
Sold 11.6% shares (-3.62 Thousand shares) Q3 2019
Avg closing price $26.60
Price range $23.87 - $30.93
New holding (+31.2 Thousand shares) Q2 2019
Avg closing price $24.98
Price range $22.10 - $28.56

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!